COVID-19
Conditions
Keywords
Covid-19, anti SARS-Co-V-2 IgM
Brief summary
The primary objective of the research is to study the relation between the presence and /or the anti SARS-Co-V-2 IgM level in an early stage of COVID-19 infection, and the evolution of the illness.
Detailed description
The secondary objective is to determinate in what manner response of IgM anti-SARS-Co-V-2 relates to patient's immunity statute, in regards to the other so-called humain seasonal coronavirus.
Interventions
None listed
Sponsors
Assistance Publique - Hôpitaux de Paris
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients ≥ 18 years; * Have been diagnosed positive of SARS-CoV-2 in the Virological Laboratory of Ambroise Paré hospital; * Have been blood sampled between 1 day and 14 days from the first clinical syndromes, and their collections of serum or plasma are conserved and accessible; * Affiliated to the social security scheme or entitled; * Informed and non-opposed to participating to the study.
Exclusion criteria
* Opposition of patient to participation to the study; * Foreign patients under french AME scheme.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hospitalization | through study completion, an average of 1 month | Absence of hospitalization versus hospitalization without ventilation during SARS-CoV-2 infection |
| Ventilation | through study completion, an average of 1 month | Non ventilation versus ventilation during Covid-19 hospitalization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Oxygenotherapy | through study completion, an average of 1 month | Use of high-flow oxygenotherapy |
| Ventilation | through study completion, an average of 1 month | Ventilation during SARS-CoV-2 infection |
| IgM anti-SARS-Co-V-2 presence | through study completion, an average of 1 month | IgM anti-SARS-Co-V-2 level |
| Patient's vital statute | through study completion, an average of 1 month | Death of hospitalized patients in Ambroise Paré hospital |
| Thoracic CT | through study completion, an average of 1 month | Thoracic CT result during SARS-CoV-2 infection |
| Hospitalization at Ambroise Paré hospital | through study completion, an average of 1 month | Hospitalization at Ambroise Paré hospital during SARS-CoV-2 infection |
Contacts
Primary ContactJean-Louis Gaillard, MD, PhD
Outcome results
None listed